Medisafe's asking price for a one-year subscription to app users' own day-by-day logs of the doses they took, for one oncology drug class, on AWS Data Exchange
$24,000.00
USD per 12-month subscription (quarterly snapshots), no patient count stated, US
“Product Overview: A snapshot of US Medisafe users who report taking an Oncology-Immunomodulator class medication in the most recent completed quarter. This self-reported de-identified data includes gender and age characteristics as well as start date of documenting medication with Medisafe, number of scheduled daily doses and daily reported doses taken in the last quarter. ... Cost/12 months Product Access Dimension that grants access to the product for subscribers. $24,000.00”
- Kind of source
- Marketplace listing
- Read on
- 2026-11-07
- Daily check
- Quote found at the source on 2026-11-07
- What to know
- An asking price for patient-reported medication data, not a realised sale. The listing's title names neutropenia drugs while its overview describes immunomodulator users (the vendor's own wording); either way it is one oncology drug class. No patient count is stated, so no per-person price can be derived. The listing dates from 2019 and its price may be stale.
- About
- Medication history
Used in
Kept as evidence; no figure on the platform is computed from it yet.